Grand River Aseptic Manufacturing
140 Front Avenue SW
About Grand River Aseptic Manufacturing
Grand River Aseptic Manufacturing was founded in 2010 as a joint venture between the Van Andel Institute and Grand Valley State University. Our company supports the life sciences industry’s growing need for high-quality, outsourced sterile parenteral manufacturing.
CEO: Thomas J. Ross
11 articles with Grand River Aseptic Manufacturing
Grand River Aseptic Manufacturing (GRAM) inked a deal with Janssen Pharmaceutical, a Johnson & Johnson company, to support the manufacturing of Janssen’s COVID-19 vaccine candidate.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 25, 2020.
Grand River Aseptic Manufacturing, a leading parenteral contract development and manufacturing organization, was recognized in Inc. Magazine's Inc. 5000 list for the fourth consecutive year.
HHS and Dept. of Defense call upon the U.S.-based CDMO to expand domestic fill/finish capacity under Operation Warp Speed.
David joins GRAM as the Vice President of Business Development.
Evaluated according to the percentage growth of annual revenue over a three-year period, this global and national recognition celebrates GRAM's superior business productivity, rapid revenue growth and ongoing customer-base expansion.
Grand River Aseptic Manufacturing, Inc. Implements Fully-Automated Serialization and Aggregation Solutions Ahead of 2023 DSCSA Deadline
Grand River Aseptic Manufacturing, Inc., a leading parenteral contract development and manufacturing organization, has implemented its fully-automated serialization and aggregation processes for commercial injectable drug products.
Grand River Aseptic Manufacturing, Inc. Expands Pharmaceutical Manufacturing Capacity with Major Equipment Purchase
Grand River Aseptic Manufacturing, Inc. (GRAM) has announced its second major equipment purchase this year: a state-of-the-art Bausch+Ströbel fully integrated high-speed filling line with SKAN isolator.
Grand River Aseptic Manufacturing Continues to Expand Capabilities with New, State-of-the-Art Colanar Syringe Filler
The Colanar FSV syringe filler will utilize the existing single-use systems already in place at GRAM and will support both small molecule APIs and biologics projects.
Based in Grand Rapids, MI, GRAM is a leading contract, development and manufacturing organization (“CDMO”) focused on the development, manufacture and finishing of parenteral pharmaceuticals.
Proceeds from the 100-meter race on Nov. 4 will be donated to Parent Project Muscular Dystrophy (PPMD), the largest U.S. nonprofit organization focused on ending Duchenne muscular dystrophy.